Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production

Diabetes

Volumn 45, Issue 8, 1996, Pages 1044-1050

  Boden, Guenther ^a,b   Chen, Xinhua ^a   Urbain, Jean Luc ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GROWTH HORMONE; HYDROCORTISONE; INSULIN;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGLYCEMIA; INSULIN CLEARANCE; INSULIN SENSITIVITY; LIVER METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0029743883     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.8.1044     Document Type: Article

References (37)

1. Jarrett RI: Rhythms in insulin and glucose. In Endocrine Rhythms. Krieger DT, Ed. New York, Raven, 1979, p. 247-258
2. Carroll KF, Nestel PJ: Diurnal variation in glucose tolerance and in insulin secretion in man. Diabetes 22:333-348, 1973
3. Roberts HG: Afternoon glucose tolerance testing: a key to the pathogenesis, early diagnosis and prognosis of diabetogenic hyperinsulinism. J Am Geriatr Soc 12:423-472, 1964
4. Izzo JL: Diurnal (24 hour) rhythm in diabetes mellitus: diurnal variations in levels of glucose in blood and urine. Proc Am Diabetes A9:247-273, 1949
5. Malherbe C, De Gasparo M, De Hertogh R, Hoet JJ: Circadian variations of blood sugar and plasma insulin levels in man. Diabetologia 5:397-404, 1969
6. Schmidt MI, Hadji-Georgopoulos A, Rendell M, Margolis S, Kowarski A: The dawn phenomenon, an early morning glucose rise: implications for diabetic intraday blood glucose variation. Diabetes Care 4:579-585, 1981
7. Clarke WL, Raymond MW, Santiago JV: Overnight basal insulin requirements in fasting insulin-dependent diabetics. Diabetes 29:79-80, 1980
8. Bolli GB, Gerich JE: The "dawn phenomenon": a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus. N Engl J Med 310:746-750, 1984
9. Boden G, Ruiz J, Urbain JL, Chen X: Evidence for a circadian rhythm of insulin secretion. Am J Physiol. In press.
10. Shimoyama R, Ray TK, Savage CR Jr, Owen OE, Boden G: In vivo and in vitro effects of antiinsulin receptor antibodies. J Clin Endocrinol Metab 59:916-923, 1984
11. Steele R, Wall JS, DeBodo RC, Altszuler N: Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187:15-24, 1956
12. Van Canter E, Mestrez F, Sturis J, Polonsky KS: Estimation of insulin secretion rates from C-peptide levels: comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368-377, 1992
13. Rechtshaffen A, Kales A: A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Washington, DC, U.S. Govt. Printing Office, 1968
14. Urbain JLC, Vekemans MC, Bouillon R, Van Cauteren J, Bex M, Mayeur SM, Van den Maegdenbergh V, Bataille G, Charkes ND, Malmud LS, DeRoo M: Characterization of gastric antral motility disturbances in diabetes using a scintigraphic technique. J Nucl Med 34:576-81, 1993
15. Boden G, Soeldner JS: A sensitive double antibody radioimmunoassay for human growth hormone (HGH): levels of serum HGH following rapid tolbutamide infusion. Diabetologia 3:413-421, 1967
16. Harris G, Faloona GR, Unger RH: Glucagon. In Methods of Hormone Radioimmunoassay. Jaffe BM, Behrmann HR, Eds. New York, Academic, 1979, p. 643-656
17. Gutmann I, Wahlefeld AW: L-lactate: determination with lactate dehydrogenase and NAD. In Methods of Enzymatic Analysis. 2nd English ed. Bergmeyer HU, Ed. New York, Academic, 1974, p. 1464-1468
18. Williamson DH: L-alanine: determination with alanine dehydrogenase. In Methods of Enzymatic Analysis. 3rd ed. Bergmeyer HU, Bergmeyer J, Grabl M, Eds. Deerfield Beach, FL, Verlag Chemie, 1984, p. 341-349
19. Van Cauter E, Desir D, Decoster C, Fery F, Balasse EO: Nocturnal decrease in glucose tolerance during constant glucose infusion. J Clin Endocrinol Metab 69:604-611, 1989
20. Shapiro ET, Tillil H, Polonsky KS, Fang VS, Rubenstein AH, Cauter EV: Oscillations in insulin secretion during constant glucose infusion in normal man: relationship to changes in plasma glucose. J Clin Endocrinol Metab 67:307-314, 1988
21. Van Cauter E, Blackman JD, Roland D, Spire JP, Refetoff S, Polonsky KS: Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep. J Clin Invest 88:934-942, 1991
22. DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15:318-368, 1992
23. Bolli GB, De Feo P, De Cosmo S, Perriello G, Ventura MM, Calcinaro F, Lolli C, Campbell P, Brunetti P, Gerich JE: Demonstration of a dawn phenomenon in normal human volunteers. Diabetes 33:1150-1153, 1984
24. Clore JN, Nestler JE, Blackard WG: Sleep-associated fall in glucose disposal and hepatic glucose output in normal humans: putative signaling mechanism linking peripheral and hepatic events. Diabetes 38:285-290, 1989
25. Rebrin K, Steil GM, Getty L, Bergman RN: Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44:1038-1045, 1995
26. Gonzalez-Manchon C, Ayuso M, Parrilla R: Control of hepatic gluconeogenesis: role of fatty acid oxidation. Arch Biochem Biophys 271:1-9, 1989
27. Boden G, Jadali F: Effects of lipid on basal carbohydrate metabolism in normal men. Diabetes 40:686-692, 1991
28. Saloranta C, Koivisto V, Widen E, Falholt K, DeFronzo RA, Harkonen M, Groop L: Contribution of muscle and liver to glucose-fatty acid cycle in humans. Am J Physiol 264:E599-E605, 1993
29. Boden G, Chen X: Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes. J Clin Invest 96:1261-1268, 1995
30. Boden G, Chen X, Ruiz J, White JV, Rossetti L: Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93:2438-2446, 1994
31. Shamoon H, Hendler R, Sherwin RS: Altered responsiveness to cortisol, epinephrine, and glucagon in insulin-infused juvenile-onset diabetics: a mechanism for diabetic instability. Diabetes 29:284-291, 1980
32. Rizza RA, Mandarino LJ, Gerich JE: Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor defect of insulin action. J Clin Endocrinol Metab 54:131-138, 1982
33. Clerc D, Wick H, Keller U: Acute Cortisol excess results in impaired insulin action on lipolysis and branched chain amino acids, but not on glucose kinetics and C-peptide concentrations in man. Metabolism 35:404-410, 1986
34. Cipres G, Urcelay E, Butta N, Ayuso MS, Parrilla R, Martin-Requero A: Loss of fatty acid control of gluconeogenesis and PDH complex flux in adrenalectomized rats. Am J Physiol 267:E528-E536, 1994
35. DeFeo P, Perriello G, Torlone E, Ventura MM, Fanelli C, Santeusanio F, Brunetti P, Gerich JE, Bolli GB: Contribution of cortisol to glucose counterregulation in humans. Am J Physiol 257:E35-E42, 1989
36. Linsell CR, Lightman SL, Mullen PE, Brown MJ, Causon RC: Orcadian rhythms of epinephrine and norepinephrine in man. J Clin Endocrinol Metab 60:1210-1215, 1985
37. Clutter WE, Bier DM, Shah SD, Cryer PE: Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. J Clin Invest 66:94-101, 1980